Erythropoietin for Management of Anemia Caused by Chemotherapy

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 1, 2012

Primary Completion Date

November 28, 2017

Study Completion Date

December 7, 2017

Conditions
Diffuse Large B-cell Lymphoma
Interventions
DRUG

Darbepoetin alfa

Darbepoietin alfa will be administered subcutaneously at a fixed dose of 360㎍. If it is impossible, administration by intravenous infusion is okay.

DRUG

R-CHOP

R-CHOP regimen is a practical procedure in patients with Diffuse Large B-cell Lymphoma. Darbepoietin alfa will be administered to these patients.

All Listed Sponsors
lead

Kosin University Gospel Hospital

OTHER

NCT02890602 - Erythropoietin for Management of Anemia Caused by Chemotherapy | Biotech Hunter | Biotech Hunter